Well I have tried to communicate with company with no reply. It's a fairly obvious question isn't it? Why is the same treatment that didn't get put forward for a CE mark in 2009 going to get put forward in 2015 with no new information? Do they think they'll get it on the back of Sirtex? Personally I can't think of many oncology services that are going to be recommending a treatment to patients that has no controlled data on efficacy. There has to be some form of capital raising coming up in the near future to pay for a controlled trial - no you can't do it for nearly free expecting patients to pay for it (!).
OSL Price at posting:
12.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)